OurWestsiderNews.com: 'Touring cat statues stop in Westminster'

Quoting the June 21st article by Ashley Reimers (Meowscarade by Pam Schmidt pictured):

"The Aar River Gallery will welcome some feline friends as the 'Tails of the Painted Cats' passes through historic Westminster.

'Tails of the Painted Cats' is a fundraising event for the Cat Care Society in Lakewood, a nonprofit organization established to improve the quality of life for homeless, injured and abused cats in the Denver metropolitan area.

Currently the litter of eye-catching cat statues is on a two-month tour of the metro area.

'This is our second year doing this fundraiser, and it’s been a lot of fun,' said Suellen Scott, CCS director of development. 'The cats are amazing to look at.'

The larger-than-life cats created by Colorado artists will be on display 608 p.m. Friday, June 29, during a wine-and-cheese reception in the gallery’s outdoor garden, 3707 W. 73rd Ave. Tickets are $10 [per person donation at the door]."

Link to the article about the Aar River Gallery event June 29th

Link to the Advance Bidding Site

Link to buy tickets to the Gala Dinner & Auction on July 28th at Lakewood Country Club

CBSA Releases 2012 Edition of Bioscience Colorado Magazine - Colorado Centers of Excellence: Elevated Thinking

The 2012 issue of Bioscience Colorado highlights centers of excellence within the state, including Cancer, Infectious Disease, Respiratory, Cardiac and Biofuels. The research the writers and experts have compiled for this issue illustrates that there are several components—infrastructure, expertise, industry connections, and patient outcomes. Each article focuses on a center and examines the elements that make it truly excellent.

The new issue also includes:

* Complete listing of every bioscience company in the state

* Annual industry financing and investment overview

* Bioscience Discovery Evaluation Grant Program (BDEGP) update

This publication is an integral part of the Association’s mission to support the Colorado bioscience community through advocacy, resources and advancement of opportunities for collaboration. It reaches thousands of bioscience, economic development, legislative, university and industry leaders.

The new magazine rolls out the industry’s new branding campaign for Bioscience in Colorado: Elevated Thinking. We have some of the top research institutions in the country and over 600 bioscience companies led by the best in the industry—creating the vision and drive to succeed. That’s why so many great ideas that impact the globe start and grow here in Colorado.

Link to the magazine pdf

Link to the Business Wire release

Link to the PitchEngine Social Media newswire

Extra Dirt: 'Give Your Plants a Fishy Treat'

Quoting from the e-newsletter of the National Home Gardening Club:

"Want to give your garden a nutritious boost? Go fish!...

Made by Bell Aquaculture (the nation's largest yellow perch farm), the fertilizer is garden- and people-safe and meets USDA specifications for organic growing. It promises faster greening and root establishment, and more intense, longer-lasting blooms. It's sold in liquid form, so it's easy to apply."

Link to the Extra Dirt online archive

More From the Suburban Jungle: 'What Happens When You Don't Fertilize Your Tomato Plants'

The Suburban Jungle's Angela Maas talks tomato plants, fish fertilizer (Bell Aquaculture's Fish Rich) and Raspberries in her June 6th posting:

"If you've ever wondered whether fertilizer was really important to the health of your plants, let me show you an experiment that I've been running in my garden this year.

I intended to grow 14 tomato plants, but when I bought plants I wound up with 18. So I planted my usual 14 and then put the other 4 in a separate location.

Since they were not sharing the same plot of dirt, I thought this was a great time to experiment.

I fertilized all of the tomato plants at planting time. I planted them all at the same depth and have watered them at the same levels consistently since planting.

After the initial fertilizer, I stopped fertilizing the four separate plants and kept on feeding the others every two weeks. I fertilize all of my other plants with a low concentration of fish fertilizer every few weeks."

Link to the full June 6th posting with photos of Angela's garden

Denver Post: 'It's a cat thing and an art thing'

"The gala's not until July 28. But bidders are already pouncing online for the 2012 "Tails of the Painted Cats" artworks. An annual fundraiser for the Cat Care Society in Lakewood, this auction and gala lure a lot of well-clawed feline fanciers. The society is a cage-free shelter for homeless and abused cats that also provides outreach and education programs. The fundraiser came about last year as part of the society's 30th anniversary. You can view all the cats and bid on them at BidOnACat.blogspot.com through July 25. The June 29th wine and cheese reception is 6 to 8 p.m. at Westminster's Aar River Gallery."

Link to the article

GEN Feature: 'Global Bioclusters Vie for Dominance'...Colorado ranks 12th in GEN's Top 15 Biotechnology Clusters

Quoting from the June 1 article by Alex Philippidis:

"The U.S. continues to enjoy the world’s largest biopharma industry by establishments (48,059; Battelle); public-company revenues ($61.6 billion in 2010; Ernst & Young); size of prescription-drug market ($307 billion; IMS); jobs (1.42 million; Battelle); venture capital ($4.733 billion last year; MoneyTree Report); R&D research (just over $100 billion in private and public spending); and patents (6,601 within classes 424, 435, and 514 last year; USPTO).

So Uncle Sam remains biopharma’s anchor—or more accurately, two anchors. California and Massachusetts are the top states in biopharma jobs, companies, venture capital raised, NIH grant funding awarded, and patents granted."

Colorado ranks 12th in GEN's Top 15 Biotechnology Clusters:

Link to the article

BCBR: 'Drug race lures local companies to fast lane'

Quoting from the June 8th article by Beth Potter:

"Merck & Co. Inc. and Amgen Inc. — two global pharmaceutical companies with operations in the Boulder Valley — appear to be on the front lines of the new and often-stealthy world of researching biosimilar drugs.

Virtually all major drug companies, including Merck and Amgen, are racing to create biosimilar drugs, after the federal government said in 2010 that it would create a quicker path to approval for such drugs as part of the new Patient Protection and Affordable Care Act...

Pharmaceutical companies have become involved in biosimilar research to protect themselves, said Holli Riebel, executive director of the Colorado Bioscience Association, an industry group in Denver.

'They (pharmaceutical companies) have made huge investments in developing biologics, which are complex molecule (drugs) that are more expensive to produce,' Riebel said.

Analysts expect that global sales of biosimilar drugs to grow to $3.7 billion in 2015, according to Datamonitor, a business research firm with offices in New York and London."

Link to the article